Omnicell PE Ratio 2010-2025 | OMCL

Current and historical p/e ratio for Omnicell (OMCL) from 2010 to 2025. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. Omnicell PE ratio as of June 04, 2025 is 25.86.

Please refer to the Stock Price Adjustment Guide for more information on our historical prices.

Omnicell PE Ratio Historical Data
Date Stock Price TTM Net EPS PE Ratio
2025-06-04 31.29 68.02
2025-03-31 34.96 $0.46 76.00
2024-12-31 44.52 $0.27 164.89
2024-09-30 43.60 $-0.39 0.00
2024-06-30 27.07 $-0.46 0.00
2024-03-31 29.23 $-0.46 0.00
2023-12-31 37.63 $-0.45 0.00
2023-09-30 45.04 $-0.77 0.00
2023-06-30 73.67 $-0.52 0.00
2023-03-31 58.67 $-0.40 0.00
2022-12-31 50.42 $0.10 504.20
2022-09-30 87.03 $1.02 85.32
2022-06-30 113.75 $1.26 90.28
2022-03-31 129.49 $1.49 86.91
2021-12-31 180.44 $1.62 111.38
2021-09-30 148.43 $1.71 86.80
2021-06-30 151.45 $1.30 116.50
2021-03-31 129.87 $0.77 168.66
2020-12-31 120.02 $0.73 164.41
2020-09-30 74.66 $0.87 85.82
2020-06-30 70.62 $1.13 62.50
2020-03-31 65.58 $1.60 40.99
2019-12-31 81.72 $1.42 57.55
2019-09-30 72.27 $1.27 56.91
2019-06-30 86.03 $1.14 75.46
2019-03-31 80.84 $0.93 86.92
2018-12-31 61.24 $0.92 66.57
2018-09-30 71.90 $1.18 60.93
2018-06-30 52.45 $1.01 51.93
2018-03-31 43.40 $0.87 49.89
2017-12-31 48.50 $0.51 95.10
2017-09-30 51.05 $-0.11 0.00
2017-06-30 43.10 $-0.22 0.00
2017-03-31 40.65 $-0.27 0.00
2016-12-31 33.90 $0.01 3390.00
2016-09-30 38.30 $0.22 174.09
2016-06-30 34.23 $0.39 87.77
2016-03-31 27.87 $0.66 42.23
2015-12-31 31.08 $0.84 37.00
2015-09-30 31.10 $0.88 35.34
2015-06-30 37.71 $0.86 43.85
2015-03-31 35.10 $0.83 42.29
2014-12-31 33.12 $0.83 39.90
2014-09-30 27.33 $0.77 35.49
2014-06-30 28.71 $0.78 36.81
2014-03-31 28.62 $0.74 38.68
2013-12-31 25.53 $0.67 38.10
2013-09-30 23.68 $0.64 37.00
2013-06-30 20.55 $0.63 32.62
2013-03-31 18.88 $0.50 37.76
2012-12-31 14.87 $0.47 31.64
2012-09-30 13.90 $0.43 32.33
2012-06-30 14.64 $0.32 45.75
2012-03-31 15.21 $0.36 42.25
2011-12-31 16.52 $0.31 53.29
2011-09-30 13.78 $0.21 65.62
2011-06-30 15.59 $0.16 97.44
2011-03-31 15.24 $0.14 108.86
2010-12-31 14.45 $0.15 96.33
2010-09-30 13.08 $0.15 87.20
2010-06-30 11.69 $0.14 83.50
2010-03-31 14.03 $0.11 127.55
2009-12-31 11.69 $0.02 584.50
Sector Industry Market Cap Revenue
Medical Medical Information Systems $1.466B $1.112B
Omnicell Inc., develops and markets end-to-end automation solutions for the medication-use process. These automation solutions contain medication and supply dispensing systems, central pharmacy storage, retrieval and packaging solutions, a bedside automation solution, a physician order management solution, a decision support application, and a Web-based procurement application. The products offered by the company enable care providers to improve patient safety and increase efficiency by lowering costs. The company also adheres to regulatory compliances and addresses issues related to population health.
Stock Name Country Market Cap PE Ratio
Veeva Systems (VEEV) United States $46.136B 58.95
Hims & Hers Health (HIMS) United States $12.000B 124.67
Tempus AI (TEM) United States $10.868B 0.00
IRhythm Technologies (IRTC) United States $4.592B 0.00
Inspire Medical Systems (INSP) United States $4.068B 63.55
Hinge Health (HNGE) United States $3.121B 0.00
Privia Health (PRVA) United States $2.805B 191.75
Enovis (ENOV) United States $1.818B 10.14
Schrodinger (SDGR) United States $1.741B 0.00
Clover Health Investments (CLOV) United States $1.567B 0.00
Phreesia (PHR) United States $1.501B 0.00
Azenta (AZTA) United States $1.310B 60.89
10x Genomics (TXG) United States $1.150B 0.00
Fulgent Genetics (FLGT) United States $0.648B 0.00
Claritev (CTEV) United States $0.605B 0.00
Butterfly Network (BFLY) United States $0.591B 0.00
Talkspace (TALK) United States $0.553B 165.25
Veradigm (MDRX) United States $0.466B 0.00
Standard BioTools (LAB) United States $0.410B 0.00
TruBridge (TBRG) United States $0.353B 784.00
Outset Medical (OM) United States $0.342B 0.00
Health Catalyst (HCAT) United States $0.275B 0.00
Nyxoah SA (NYXH) Belgium $0.263B 0.00
SOPHiA GENETICS SA (SOPH) Switzerland $0.200B 0.00
KORU Medical Systems (KRMD) United States $0.130B 0.00
Pulmonx (LUNG) United States $0.124B 0.00
EUDA Health Holdings (EUDA) Singapore $0.118B 0.00
American Well (AMWL) United States $0.108B 0.00
MDxHealth SA (MDXH) Belgium $0.101B 0.00
CareCloud (CCLD) United States $0.091B 3.45
111 (YI) China $0.071B 0.00
HeartBeam (BEAT) United States $0.057B 0.00
P3 Health Partners (PIII) United States $0.047B 0.00
Zepp Health (ZEPP) Netherlands $0.035B 0.00
Zhongchao (ZCMD) China $0.028B 0.00
ImmunoPrecise Antibodies (IPA) Canada $0.026B 0.00
Streamline Health Solutions (STRM) United States $0.022B 0.00
Precipio (PRPO) United States $0.016B 0.00
Bullfrog AI Holdings (BFRG) United States $0.016B 0.00
MSP Recovery (MSPR) United States $0.012B 0.00
Strata Skin Sciences (SSKN) United States $0.010B 0.00
Predictive Oncology (POAI) United States $0.009B 0.00
Movano (MOVE) United States $0.004B 0.00
HeartSciences (HSCS) United States $0.004B 0.00
Evaxion - (EVAX) Denmark $0.004B 0.00
Mobile-health Network Solutions (MNDR) Singapore $0.004B 0.00
Tivic Health Systems (TIVC) United States $0.004B 0.00
Healthcare Triangle (HCTI) United States $0.000B 0.00
Future Health ESG (FHLT) United States $0.000B 0.00